QCM
- Product code
- QCM
- Device name
- ß-Galactocerebrosidase (Galc) Newborn Screening Test System
- Device class
- Class 2
- 21 CFR
- 21 CFR 862.1488
- Medical specialty
- Clinical Chemistry
- Marketing pathway
- 510(K)
- Flag
- Third-party review eligible
FDA classification definition
For quantitative measurement of the activity of ß-galactocerebrosidase (GALC) from newborn dried blood spot specimens as an aid in screening newborns for Krabbe disease.
Official FDA classification page: QCM
Classification and pathway per current FDA publications. Data from openFDA (CC0).